POM NASDAQ Week ended 24 Jul 2026

Weekly Investor Report

POMDOCTOR LIMITED American Depositary Shares · Healthcare · Pharmaceutical Retailers

Open interactive chart View report data
Latest close 0.71 USD
-37.2% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -81.5% below the Trend Line and sits at 0.1% of its 52-week range. The latest completed week returned -37.2%, after a -52.0% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 47/100. Near-term considerations: volume confirmation is below normal; earnings are due in 13d.

Setup score 25 out of 100
Latest Close 0.71 USD 24 Jul 2026
1W Return -37.2% latest completed week
4W Return -52.0% short-term follow-through
12W Return -89.6% quarterly tape
Trend Breadth 0.0% 0 of 42 weeks active
Volume Ratio 0.0x vs 13-week average
What is working
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Next-week expectancy is negative at 42.47% based on similar historical setup states.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -37.2% Latest completed week; four-week move -52.0%. Indicator stack 0/91 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 42.47% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 47/100 37 relevant articles in the latest sentiment read. Event risk 13d Next report is scheduled for 13 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -81.5% below the Trend Line and sits at 0.1% of its 52-week range. The latest completed week returned -37.2%, after a -52.0% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.0x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.0112-week average 0.13

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.01Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -52.0% over four weeks, -89.6% over 12 weeks, and - over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W-37.2%
4W-52.0%
12W-89.6%
26W-86.3%
52W-
Active trend streak0 weeks
Active weeks in one year0
Trend breadth0.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.56Latest activity-pressure read.
Pressure change390.7%Four-week change in activity pressure.
Leadership-Latest relative-leadership reading.
RS change-Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Dec 2025 Field coverage 58% Model confidence 55%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength45/100Blend of value, momentum, and quality. Underlying universe rank 56; rank 1 is best.
Value47/100Relative valuation strength. Underlying universe rank 54; rank 1 is best.
Quality46/100Profitability and accounting quality. Underlying universe rank 55; rank 1 is best.
Momentum48/100Medium-term price momentum. Underlying universe rank 53; rank 1 is best.
Growth48/100Revenue and earnings growth. Underlying universe rank 53; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
0.0x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-30.9%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
13.1%
Gross profit retained from each unit of revenue.
Operating margin
-29.5%
Operating profit retained from revenue.
Free-cash-flow margin
-36.9%
Free cash flow generated from revenue.
Return on invested capital
-
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
16.7%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
4/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-
Net share repurchases relative to market value.
Shareholder yield
-
Dividend yield plus net buyback yield.
Net debt / EBITDA
-3.8x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment47/100

Weighted news tone is neutral across 37 relevant articles.

10 positive · 17 neutral · 10 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings13dNext report is scheduled for 13 Aug 2026; event risk rises as the date approaches.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-99.4%Distance below the 52-week high.
13-week volatility29.8%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher11 of 2615 weeks finished lower.
Best week+58.0%Week of 13 Mar.
Worst week-80.3%Week of 8 May.
Latest week-37.2%Week of 24 Jul.

Shape of recent returns

Strong gains9
Modest gains2
Flat weeks0
Modest losses4
Sharp losses11
Recent vol29.8%13-week weekly-return volatility.
Base vol27.4%52-week weekly-return volatility.
Up/down split16/25Count of positive and negative weeks in the 52-week window.
Average skew19.4% / -18.3%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape29/100

Trend, activity pressure, participation, and risk combine to a 29/100 tape read.

 Indicator analysis29/100

Latest 12-week confirmation: trend 0/12, activity pressure 12/12, relative leadership 0/12.

Activity pressure 0.01; No reversal markers Next-Week ExpectancyNegative 42.47%

Next-week expectancy is negative with a 42.47% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors45/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 50 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment47/100

Weighted news tone is neutral across 37 relevant articles.

POM|PomDoctor Ltd|Price:0.714|Chg%:+0.034 Insiders50/100

No recent insider transaction evidence is stored.

 Earnings13d

Next report is scheduled for 13 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 20260.71 USD-37.2%3.84 USD21.22 USD0.56-532.1KOff
17 Jul 20261.13 USD-26.1%4.03 USD21.72 USD0.56-225.9KOff
10 Jul 20261.53 USD-4.4%4.17 USD22.24 USD0.47-97.6KOff
3 Jul 20261.60 USD8.1%4.37 USD22.77 USD0.36-255.9KOff
26 Jun 20261.48 USD14.4%7.59 USD23.33 USD0.11-504.2KOff
19 Jun 20261.29 USD-29.2%10.13 USD23.92 USD0.10-5.2MOff
12 Jun 20261.83 USD2.7%12.82 USD24.55 USD0.12-11.6MOff
5 Jun 20261.78 USD-5.2%15.04 USD25.20 USD0.22-3.6MOff
29 May 20261.88 USD-15.1%18.19 USD25.88 USD0.32-4.8MOff
22 May 20262.21 USD8.4%21.37 USD26.61 USD0.44-5.7MOff
15 May 20262.04 USD51.1%24.08 USD27.37 USD0.55-345.3MOff
8 May 20261.35 USD-80.3%26.52 USD28.19 USD0.56-27.6MOff
1 May 20266.84 USD-3.2%29.09 USD29.09 USD0.50-11.8MOff
24 Apr 20267.07 USD-0.5%-29.85 USD0.35-12.3MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.